AIEgen-Based Photoactivatable Polymeric Prodrug Nanoplatform for Combined Photodynamic-Chemotherapy
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Xiaoqing Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, College of Pharmacy, Gannan Medical University, Ganzhou 341000, Chin…. Hauptthemen laut MEDLINE: Prodrugs, Photochemotherapy, Photosensitizing Agents, Paclitaxel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Wuhan Business University, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The combination of photodynamic therapy (PDT) and chemotherapy is an innovative cancer treatment strategy, but its clinical application faces challenges: (1) conventional photosensitizers exhibit fluorescence quenching and reduced ROS generation due to aggregation in aqueous environments, and (2) existing nanocarriers suffer from low drug loading efficiency, premature leakage, and systemic toxicity. To overcome these issues, we developed a photoactivatable codelivery system integrating a red-emissive AIEgen photosensitizer (BTPTT-NTPE, BC) with a ROS-responsive polymeric paclitaxel (PTX) prodrug. Harnessing the AIE effect, the AIEgen photosensitizer in its aggregated state within the codelivery system not only resolves the fluorescence quenching issue common to conventional photosensitizers but also demonstrates exceptional photostability and efficient ROS generation. The BC@PTP prodrug achieves a high PTX loading (18.0%) and enables spatiotemporally controlled drug release via light-activated prodrug cleavage. This multifunctional system demonstrates remarkable antitumor efficacy through synergistic PDT-chemotherapy effects in a HeLa-bearing mouse animal model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, College of Pharmacy, Gannan Medical University, Ganzhou 341000, China.
- Equine Science Research and Horese Doping Control Laboratory, Hubei Provincial Engineering Research Center of Racing Horse Detection and Application Transformation, Wuhan Business University, Wuhan 430056, China.
- Guangxi Key Laboratory of Electrochemical and Magneto-chemical Functional Materials, College of Chemistry and Bioengineering, Guilin University of Technology, Guilin 541006, China.
ORCID-Profile: Shijie Zhen, Man Zhou
Förderung
- Wuhan Business University
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Gannan Medical University
Zitieren
APA
Yang, X., Min, X., Yi, X., Nan, X., Qin, C., Liu, C., Gong, Z., Fang, L., Zhen, S., & Zhou, M. (2025). AIEgen-Based Photoactivatable Polymeric Prodrug Nanoplatform for Combined Photodynamic-Chemotherapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00763
Vancouver
Yang X, Min X, Yi X, Nan X, Qin C, Liu C, et al. AIEgen-Based Photoactivatable Polymeric Prodrug Nanoplatform for Combined Photodynamic-Chemotherapy. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00763
BibTeX
@article{Yang2025,
author = {Yang, Xiaoqing and Min, Xuehong and Yi, Xiaoqing and Nan, Xinru and Qin, Chendi and Liu, Chenghao and Gong, Ziyue and Fang, Linjian and Zhen, Shijie and Zhou, Man},
title = {AIEgen-Based Photoactivatable Polymeric Prodrug Nanoplatform for Combined Photodynamic-Chemotherapy},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00763}
}
EUVIMED